# Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse

> **NCT05569031** · PHASE4 · COMPLETED · sponsor: **Zagazig University** · enrollment: 52 (actual)

## Conditions studied

- Opiate Withdrawal Syndrome

## Interventions

- **DRUG:** Venlafaxine
- **DRUG:** Lofexidine

## Key facts

- **NCT ID:** NCT05569031
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2021-12-15
- **Final completion:** 2022-06-15
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2022-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05569031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05569031, "Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05569031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*